Last reviewed · How we verify

NCT05873855

Acceptability, Feasibility, and Preliminary Impact of a Web-based, HIV Prevention Toolkit With Cisgender Male Couples in Lima, Peru

Completed NA Last updated 28 July 2025
What this trial tests

NA trial testing Para ti, para mi, para nosotros (P3) in HIV Infections in 148 participants. Completed in 30 June 2025.

Timeline
27 December 2022
Primary endpoint
26 April 2024
30 June 2025

Quick facts

Lead sponsorFlorida International University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment148
Start date27 December 2022
Primary completion26 April 2024
Estimated completion30 June 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Florida International University

Who can join

18 and older, male only, with HIV Infections or Hiv. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This digital couples-based HIV/STI prevention intervention project will determine preliminary efficacy to improve uptake of evidence-based strategies and a tailored prevention plan among cisgender male couples who are in a relationship (defined as greater than 3 months or more).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Assessing a Couples-Based, Digital HIV Serostatus-Neutral Intervention (Para Ti, Para Mí, Para Nosotros) for Adult Cisgender Sexual Minority Male Couples in Lima, Peru: Protocol for a 6-Month Pilot Randomized Controlled Trial.
    Mitchell JW, Bursac Z, Diaz D, Reyes Diaz EM, et al · · 2024 · cited 1× · PMID 39388228 · DOI 10.2196/63106

Verify or expand the search:

Other recruiting trials for HIV Infections

Currently open trials in the same condition.

Other Florida International University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05873855.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing